Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: CAS:623-37-0 (
3-hexanol
)
32
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The temperature dependence of the enantioselectivity of Candida antarctica
lipase
B for
3-hexanol
, 2-butanol, 3-methyl-2-butanol, 3,3-dimethyl-2-butanol, and 1-bromo-2-butanol revealed that the differential activation entropy, deltaR-SdeltaS, was as significant as the differential activation enthalpy, DeltaR-SdeltaH, to the enantiomeric ratio, E. 1-Bromo-2-butanol, with isosteric substituents, displayed the largest deltaR-SdeltaS.
3-Hexanol
displayed, contrary to other sec-alcohols, a positive deltaR-SdeltaS. In other words, for
3-hexanol
the preferred R-enantiomer is not only favored by enthalpy but also by entropy. Molecular dynamics (MD) simulations and systematic search calculations of the substrate accessible volume within the active site revealed that the (R)-
3-hexanol
transition state (TS) accessed a larger volume within the active site than the (S)-
3-hexanol
TS. This correlates well with the higher TS entropy of (R)-
3-hexanol
. In addition, this enantiomer did also yield a higher number of allowed conformations, N, from the systematic search routines, than did the S-enantiomer. The substrate accessible volume was greater for the enantiomer preferred by entropy also for 2-butanol. For 3,3-dimethyl-2-butanol, however, neither MD-simulations nor systematic search calculations yielded substrate accessible volumes that correlate to TS entropy. Ambiguous results were achieved for 3-methyl-2-butanol.
...
PMID:Substrate entropy in enzyme enantioselectivity: an experimental and molecular modeling study of a lipase. 1202 45